Octavia Wealth Advisors LLC Sells 11,848 Shares of The Procter & Gamble Company (NYSE:PG)

Octavia Wealth Advisors LLC lowered its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 17.2% during the fourth quarter, HoldingsChannel reports. The firm owned 57,185 shares of the company’s stock after selling 11,848 shares during the quarter. Procter & Gamble makes up 1.5% of Octavia Wealth Advisors LLC’s investment portfolio, making the stock its 22nd largest position. Octavia Wealth Advisors LLC’s holdings in Procter & Gamble were worth $8,380,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Dfpg Investments LLC increased its holdings in shares of Procter & Gamble by 1.7% during the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock worth $3,680,000 after acquiring an additional 424 shares during the last quarter. Garrett Wealth Advisory Group LLC increased its holdings in shares of Procter & Gamble by 6.3% during the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock worth $645,000 after acquiring an additional 260 shares during the last quarter. N.E.W. Advisory Services LLC increased its holdings in shares of Procter & Gamble by 14.6% during the 3rd quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock worth $13,772,000 after acquiring an additional 12,016 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Procter & Gamble by 0.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock worth $2,298,184,000 after acquiring an additional 131,339 shares during the last quarter. Finally, Miracle Mile Advisors LLC increased its holdings in shares of Procter & Gamble by 105.5% during the 4th quarter. Miracle Mile Advisors LLC now owns 59,363 shares of the company’s stock worth $8,699,000 after acquiring an additional 30,473 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG stock traded up $0.62 on Tuesday, hitting $156.07. 2,171,137 shares of the company’s stock were exchanged, compared to its average volume of 6,799,250. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.64 and a quick ratio of 0.44. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $163.14. The stock has a market cap of $367.24 billion, a P/E ratio of 26.17, a price-to-earnings-growth ratio of 3.18 and a beta of 0.44. The company has a 50 day moving average of $159.27 and a 200 day moving average of $152.70.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.14. The business had revenue of $21.44 billion during the quarter, compared to the consensus estimate of $21.48 billion. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. Procter & Gamble’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $1.59 EPS. On average, equities research analysts predict that The Procter & Gamble Company will post 6.45 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $1.0065 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.58%. Procter & Gamble’s dividend payout ratio is presently 62.98%.

Insider Activity

In related news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares of the company’s stock, valued at $768,256.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 279,063 shares of company stock valued at $43,187,745. Company insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on PG. JPMorgan Chase & Co. decreased their target price on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Wells Fargo & Company upped their price objective on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Barclays upped their price objective on Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a report on Friday. Finally, Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the company from $160.00 to $175.00 in a report on Monday, March 11th. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $168.53.

Read Our Latest Report on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.